| Year |
Citation |
Score |
| 2016 |
Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A. Novel C-Ring-Hydroxy-substituted Controlled Deactivation Cannabinergic Analogues. Journal of Medicinal Chemistry. PMID 27367336 DOI: 10.1021/acs.jmedchem.6b00717 |
0.4 |
|
| 2016 |
Järbe TU, LeMay BJ, Thakur GA, Makriyannis A. A High Efficacy Cannabinergic Ligand (AM4054) used as a Discriminative Stimulus: Generalization to other Adamantyl Analogs and Δ(9)-THC in Rats. Pharmacology, Biochemistry, and Behavior. PMID 27264437 DOI: 10.1016/j.pbb.2016.06.001 |
0.56 |
|
| 2016 |
Gifford RS, Raghav JG, Järbe TUC. Does Agonist Efficacy Alter the In Vivo Effects of Cannabinoids: Girl, Could We Get Much 'Higher'? Neuropathology of Drug Addictions and Substance Misuse. 1: 722-730. DOI: 10.1016/B978-0-12-800213-1.00067-5 |
0.56 |
|
| 2015 |
Järbe TU, Gifford RS, Zvonok A, Makriyannis A. [INCREMENT]9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats. Behavioural Pharmacology. PMID 26397760 DOI: 10.1097/FBP.0000000000000196 |
0.56 |
|
| 2015 |
Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology. 232: 2751-61. PMID 25772338 DOI: 10.1007/s00213-015-3907-0 |
0.56 |
|
| 2015 |
Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, et al. Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. Journal of Medicinal Chemistry. 58: 665-81. PMID 25470070 DOI: 10.1021/jm501165d |
0.56 |
|
| 2014 |
Järbe TU, Gifford RS. "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays. Life Sciences. 97: 64-71. PMID 23891559 DOI: 10.1016/j.lfs.2013.07.011 |
0.56 |
|
| 2013 |
Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Controlled-deactivation cannabinergic ligands. Journal of Medicinal Chemistry. 56: 10142-57. PMID 24286207 DOI: 10.1021/jm4016075 |
0.56 |
|
| 2012 |
Järbe TU, Tai S, LeMay BJ, Nikas SP, Shukla VG, Zvonok A, Makriyannis A. AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice. Psychopharmacology. 220: 417-26. PMID 21989802 DOI: 10.1007/s00213-011-2491-1 |
0.56 |
|
| 2011 |
Trivedi MS, Jarbe T. A brief review on recent developments in animal models of schizophrenia. Indian Journal of Pharmacology. 43: 375-80. PMID 21844988 DOI: 10.4103/0253-7613.83104 |
0.56 |
|
| 2011 |
Järbe TU, Deng H, Vadivel SK, Makriyannis A. Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats. Behavioural Pharmacology. 22: 498-507. PMID 21836461 DOI: 10.1097/FBP.0b013e328349fbd5 |
0.56 |
|
| 2010 |
Järbe TU, Gifford RS, Makriyannis A. Antagonism of ∆â¹-THC induced behavioral effects by rimonabant: time course studies in rats. European Journal of Pharmacology. 648: 133-8. PMID 20854804 DOI: 10.1016/j.ejphar.2010.09.006 |
0.56 |
|
| 2008 |
Järbe TU, LeMay BJ, Olszewska T, Vemuri VK, Wood JT, Makriyannis A. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats. Pharmacology, Biochemistry, and Behavior. 91: 84-90. PMID 18640150 DOI: 10.1016/j.pbb.2008.06.014 |
0.56 |
|
| 2007 |
Järbe TU, DiPatrizio NV, Li C, Makriyannis A. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats. Behavioural Pharmacology. 18: 673-80. PMID 17912052 DOI: 10.1097/FBP.0b013e3282f00bbf |
0.56 |
|
| 2006 |
Järbe TU, Ross T, DiPatrizio NV, Pandarinathan L, Makriyannis A. Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats. Pharmacology, Biochemistry, and Behavior. 85: 243-52. PMID 16996123 DOI: 10.1016/j.pbb.2006.08.006 |
0.56 |
|
| 2006 |
Järbe TU, Lamb RJ, Liu Q, Makriyannis A. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356). Psychopharmacology. 188: 315-23. PMID 16953384 DOI: 10.1007/s00213-006-0517-x |
0.56 |
|
| 2005 |
Järbe TU, DiPatrizio NV. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats. Behavioural Pharmacology. 16: 373-80. PMID 16148441 DOI: 10.1097/00008877-200509000-00009 |
0.56 |
|
| 2005 |
Lu D, Meng Z, Thakur GA, Fan P, Steed J, Tartal CL, Hurst DP, Reggio PH, Deschamps JR, Parrish DA, George C, Järbe TU, Lamb RJ, Makriyannis A. Adamantyl cannabinoids: a novel class of cannabinergic ligands. Journal of Medicinal Chemistry. 48: 4576-85. PMID 15999995 DOI: 10.1021/jm058175c |
0.56 |
|
| 2004 |
Järbe TU, DiPatrizio NV, Lu D, Makriyannis A. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats. Behavioural Pharmacology. 15: 517-21. PMID 15472574 DOI: 10.1097/00008877-200411000-00008 |
0.56 |
|
| 2003 |
Järbe TU, DiPatrizio NV, Li C, Makriyannis A. The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats. Pharmacology, Biochemistry, and Behavior. 75: 809-21. PMID 12957223 DOI: 10.1016/S0091-3057(03)00168-0 |
0.56 |
|
| 2003 |
Järbe TU, Lamb RJ, Liu Q, Makriyannis A. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. European Journal of Pharmacology. 466: 121-7. PMID 12679148 DOI: 10.1016/S0014-2999(03)01491-2 |
0.56 |
|
| 2002 |
Järbe TU, Andrzejewski ME, DiPatrizio NV. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. Pharmacology, Biochemistry, and Behavior. 73: 911-9. PMID 12213538 DOI: 10.1016/S0091-3057(02)00938-3 |
0.56 |
|
| 2001 |
Järbe TU, Lamb RJ, Lin S, Makriyannis A. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology. 156: 369-80. PMID 11498713 DOI: 10.1007/s002130100730 |
0.56 |
|
| 2001 |
Lamb RJ, Järbe TU. Effects of fluvoxamine on ethanol-reinforced behavior in the rat. The Journal of Pharmacology and Experimental Therapeutics. 297: 1001-9. PMID 11356922 |
0.56 |
|
| 2000 |
Lamb RJ, Järbe TU, Makriyannis A, Lin S, Goutopoulos A. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing. European Journal of Pharmacology. 398: 251-8. PMID 10854837 DOI: 10.1016/S0014-2999(00)00318-6 |
0.56 |
|
| 2000 |
Järbe TU, Lamb RJ, Lin S, Makriyannis A. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication. Behavioural Pharmacology. 11: 81-6. PMID 10821212 |
0.56 |
|
| 1999 |
Järbe TU, Lamb RJ. Effects of lithium dose (UCS) on the acquisition and extinction of a discriminated morphine aversion: tests with morphine and delta9-THC. Behavioural Pharmacology. 10: 349-58. PMID 10780803 |
0.56 |
|
| 1999 |
Järbe TU, Lamb RJ. Discriminated taste aversion and context: a progress report. Pharmacology, Biochemistry, and Behavior. 64: 403-7. PMID 10515321 DOI: 10.1016/S0091-3057(99)00052-0 |
0.56 |
|
| 1998 |
Järbe TU, Sheppard R, Lamb RJ, Makriyannis A, Lin S, Goutopoulos A. Effects of delta-9-tetrahydrocannabinol and (R)-methanandamide on open-field behavior in rats. Behavioural Pharmacology. 9: 169-74. PMID 10065936 |
0.56 |
|
| 1998 |
Järbe TU, Lamb RJ, Makriyannis A, Lin S, Goutopoulos A. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology. 140: 519-22. PMID 9888629 DOI: 10.1007/s002130050797 |
0.56 |
|
| 1997 |
Lamb RJ, Järbe TU. Multielemental stimulus control: effects of saccharin concentration on a discriminated morphine-saccharin taste aversion. Experimental and Clinical Psychopharmacology. 5: 123-9. PMID 9234048 DOI: 10.1037/1064-1297.5.2.123 |
0.56 |
|
| 1995 |
Järbe TU, Lamb RJ. Discriminated conditioned taste aversion for studying multi-element stimulus control. Behavioural Pharmacology. 6: 149-155. PMID 11224322 |
0.56 |
|
| 1993 |
Järbe TU, Hiltunen AJ, Mathis DA, HanÅs L, Breuer A, Mechoulam R. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison. The Journal of Pharmacology and Experimental Therapeutics. 264: 561-9. PMID 8382275 |
0.56 |
|
| 1993 |
Rijnders HJ, Jarbe TUC, Slangen JL. In a low- versus high-dose drug discrimination task, random reinforcement in one drug state alters discriminative control only in that state Behavioural Pharmacology. 4: 37-45. |
0.56 |
|
| 1993 |
Jarbe TUC, Rijnders HJ, Slangen JL. Random reinforcement selectively deteriorates drug discriminative stimulus control in rats Nida Research Monograph Series. 256. |
0.56 |
|
| 1992 |
Kostowski W, Dyr W, Krzascik P, Järbe T, Archer T. 5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety. Pharmacology & Toxicology. 71: 24-30. PMID 1387935 |
0.56 |
|
| 1991 |
Järbe TU, Mathis DA. Discriminative stimulus functions of cannabinoids/cannabimimetics. Nida Research Monograph. 75-99. PMID 1369683 |
0.56 |
|
| 1989 |
Hiltunen AJ, Järbe TU. Discriminative stimulus properties of ethanol: effects of cumulative dosing and Ro 15-4513. Behavioural Pharmacology. 1: 133-140. PMID 11175396 |
0.56 |
|
| 1989 |
Järbe TU, Hiltunen AJ, Mechoulam R. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons. The Journal of Pharmacology and Experimental Therapeutics. 250: 1000-5. PMID 2550611 |
0.56 |
|
| 1989 |
Jarbe TUC, Hiltunen AJ, Swedberg MDB. Compound drug discrimination learning Drug Development Research. 16: 111-122. |
0.56 |
|
| 1989 |
Hiltunen AJ, Jarbe TUC. Discriminative stimulus- and schedule-induced rate effects of ethanol in combination with the proposed ethanol antidote Ro 15-4513 Drug Development Research. 16: 237-245. |
0.56 |
|
| 1989 |
Jarbe TUC, Hiltunen AJ, Mechoulam R. Subjectively experienced cannabis effects in animals Drug Development Research. 16: 385-393. |
0.56 |
|
| 1988 |
Archer T, Hiltunen AJ, Järbe TU, Kamkar MR, Luthman J, Sundström E, Teiling A. Hyperactivity and instrumental learning deficits in methylazoxymethanol-treated rat offspring. Neurotoxicology and Teratology. 10: 341-7. PMID 3226377 DOI: 10.1016/0892-0362(88)90037-2 |
0.56 |
|
| 1988 |
Danysz W, Plaznik A, Kostowski W, Malatynska E, Järbe TU, Hiltunen AJ, Archer T. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacology & Toxicology. 62: 42-50. PMID 2965810 |
0.56 |
|
| 1987 |
Mechoulam R, Lander N, Srebnik M, Breuer A, Segal M, Feigenbaum JJ, Jarbe TU, Consroe P. Stereochemical requirements for cannabimimetic activity. Nida Research Monograph. 79: 15-30. PMID 3125475 |
0.56 |
|
| 1986 |
Archer T, Mohammed AK, Danysz W, Järbe TU, Jonsson G. Attenuation of sensory preconditioning by noradrenaline depletion in the rat. Behavioural Brain Research. 20: 47-56. PMID 3718664 DOI: 10.1016/0166-4328(86)90100-2 |
0.56 |
|
| 1986 |
Järbe TU. State-dependent learning and drug discriminative control of behaviour: an overview. Acta Neurologica Scandinavica. Supplementum. 109: 37-59. PMID 3535350 |
0.56 |
|
| 1984 |
Järbe TU, Johansson B. Interaction between drug discriminative stimuli and exteroceptive, sensory signals. Behavioral Neuroscience. 98: 686-94. PMID 6466444 DOI: 10.1037//0735-7044.98.4.686 |
0.56 |
|
| 1982 |
Järbe TU, Hiltunen AJ, Swedberg MD. Ethanol as a discriminative stimulus: effects of cyanamide, acetaldehyde and chlormethiazole. Medical Biology. 60: 298-306. PMID 7162223 |
0.56 |
|
| 1982 |
Jarbe TUC, Swedberg MDB. Differences in the stimulus effects of CNS depressant drugs as evidenced by drug vs. drug discrimination procedures Psychopharmacology. 76: No. 22. |
0.56 |
|
| 1982 |
Swedberg MDB, Jarbe TUC. Morphine cue saliency: Limits of discriminability and third state perception by pigeons Psychopharmacology. 76: No. 44. |
0.56 |
|
| 1981 |
Järbe TU, Sterner U, Hjerpe C. Conditioning of an interoceptive drug stimulus to different exteroceptive contexts. Psychopharmacology. 73: 23-6. PMID 6785784 |
0.56 |
|
| 1981 |
Jarbe TUC, Swedberg MDB. Differences in the stimulus effects of CNS depressant substances as evidenced by drug vs. drug discrimination techniques Acta Pharmacologica Et Toxicologica Supplementum. 49: No. 45. |
0.56 |
|
| 1980 |
Järbe TU. LDS-25 as a discriminative stimulus for response selection by pigeons. Pharmacology, Biochemistry, and Behavior. 13: 549-54. PMID 6107936 |
0.56 |
|
| 1978 |
Jarbe TUC. Δ9-Tetrahydrocannabinol: Tolerance after noncontingent exposure in rats Archives Internationales De Pharmacodynamie Et De Therapie. 231: 49-56. PMID 637625 |
0.56 |
|
| 1978 |
Swedberg MD, Loman P, Järbe TU. Effects of chlormethiazole (Heminevrin) on drug discrimination and open-field behavior in gerbils. Psychopharmacology. 59: 165-70. PMID 103119 |
0.56 |
|
| 1977 |
Jarbe TUC, Henriksson BG, Ohlin GC. Δ9-THC as a discriminative cue in pigeons: effects of Δ8-THC, CBD, and CBN Archives Internationales De Pharmacodynamie Et De Therapie. 228: 68-72. PMID 921403 |
0.56 |
|
| 1977 |
Jarbe TUC. Alcohol discrimination in gerbils: interactions with bemegride, DH 524, amphetamine, and Δ9 THC Archives Internationales De Pharmacodynamie Et De Therapie. 227: 118-129. PMID 901060 |
0.56 |
|
| 1977 |
Jarbe TUC, Ohlin Ch. G. Interactions between alcohol and other drugs on open field and temperature measurements in gerbils Archives Internationales De Pharmacodynamie Et De Therapie. 227: 106-117. PMID 901059 |
0.56 |
|
| 1977 |
Jarbe TUC, Johansson JO. Pentobarbital, diazepam and bemegride: Their effects on open field behavior in the gerbil (Meriones unguiculatus) Archives Internationales De Pharmacodynamie Et De Therapie. 225: 88-97. PMID 849067 |
0.56 |
|
| 1977 |
Järbe TUC, Holmgren B. Discriminative properties of pentobarbital after repeated noncontingent exposure in gerbils Psychopharmacology. 53: 39-44. PMID 407612 DOI: 10.1007/BF00426692 |
0.56 |
|
| 1976 |
Johansson JO, Jarbe TUC. Physostigmine as a discriminative cue in rats Archives Internationales De Pharmacodynamie Et De Therapie. 219: 97-102. PMID 1267546 |
0.56 |
|
| 1975 |
Johansson JO, Jarbe TUC, Henriksson BG. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats Tit Journal of Life Sciences. 5: 17-28. PMID 1188935 |
0.56 |
|
| 1974 |
Johansson JO, Henriksson BG, Jarbe TUC. Effects of Δ8-THC on dissociation of conditioned avoidance responding in tolerant and nontolerant rats Physiological Psychology. 2: 431-432. DOI: 10.3758/BF03333052 |
0.56 |
|
| 1973 |
Sjoden PO, Jarbe TUC, Henriksson BG. Effects of long term administration and withdrawal of tetrahydrocannabinols (Δ8 THC and Δ9 THC) on open field behavior in rats Pharm.Biochem.Behav.. 1: 243-249. PMID 4798094 |
0.56 |
|
| 1973 |
Sjoden PO, Jarbe TUC, Henriksson BG. Influence of tetrahydrocannabinols (Δ8 THC and Δ9 THC) on body weight, food, and water intake in rats Pharm.Biochem.Behav.. 1: 395-399. |
0.56 |
|
| Show low-probability matches. |